S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

NewAge Stock Forecast, Price & News

-0.03 (-2.36%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.20 million shs
Average Volume
1.73 million shs
Market Capitalization
$169.62 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive NBEV News and Ratings via Email

Sign-up to receive the latest news and ratings for NewAge and its competitors with MarketBeat's FREE daily newsletter.

NewAge logo

About NewAge

NewAge Inc is engaged in the business of developing, marketing, selling, and distributing a portfolio of healthy products. It offers a portfolio of healthy products with its brands across platforms, such as health & wellness, inner & outer beauty, and nutrition & weight management. Its partner companies include ARIIX, Noni, LIMU, and ZENNOA. The company was founded by Neil Fallon on April 26, 2010 and is headquartered in Denver, CO.


See More Headlines

Industry, Sector and Symbol

Malt beverages
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$279.47 million
Book Value
$1.62 per share


Net Income
$-39.34 million
Pretax Margin




Free Float
Market Cap
$169.62 million

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

2.11 out of 5 stars

Consumer Staples Sector

95th out of 185 stocks

Malt Beverages Industry

5th out of 6 stocks

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

NewAge (NASDAQ:NBEV) Frequently Asked Questions

Is NewAge a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NewAge in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NewAge stock.
View analyst ratings for NewAge
or view top-rated stocks.

How has NewAge's stock been impacted by Coronavirus?

NewAge's stock was trading at $1.72 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NBEV shares have decreased by 27.9% and is now trading at $1.24.
View which stocks have been most impacted by COVID-19

When is NewAge's next earnings date?

NewAge is scheduled to release its next quarterly earnings announcement on Tuesday, March 15th 2022.
View our earnings forecast for NewAge

How were NewAge's earnings last quarter?

NewAge, Inc. (NASDAQ:NBEV) posted its earnings results on Tuesday, November, 9th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.08. NewAge had a negative net margin of 1.62% and a negative trailing twelve-month return on equity of 22.01%. During the same period in the prior year, the firm posted ($0.14) earnings per share.
View NewAge's earnings history

What price target have analysts set for NBEV?

2 analysts have issued twelve-month price objectives for NewAge's shares. Their forecasts range from $6.00 to $6.00. On average, they anticipate NewAge's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 383.9% from the stock's current price.
View analysts' price targets for NewAge
or view top-rated stocks among Wall Street analysts.

Who are NewAge's key executives?

NewAge's management team includes the following people:
  • Brent David Willis, Chief Executive Officer & Director
  • Mark Wilson, Group President
  • Phil Lewis, Senior Vice President-Operations
  • Kevin Manion, Chief Financial Officer
  • Blake Heringer, Chief Information Officer

What other stocks do shareholders of NewAge own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NewAge investors own include (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Cronos Group (CRON), Advanced Micro Devices (AMD), Micron Technology (MU), NIO (NIO), BHP Group (BHP), (APHA) and General Electric (GE).

What is NewAge's stock symbol?

NewAge trades on the NASDAQ under the ticker symbol "NBEV."

Who are NewAge's major shareholders?

NewAge's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (1.58%), Renaissance Technologies LLC (1.08%), Morgan Stanley (0.63%), Trek Financial LLC (0.49%), Millennium Management LLC (0.46%) and Marshall Wace LLP (0.42%). Company insiders that own NewAge stock include Ed Brennan and Timothy J Haas.
View institutional ownership trends for NewAge

Which institutional investors are selling NewAge stock?

NBEV stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Dimensional Fund Advisors LP, Davy Global Fund Management Ltd, Renaissance Technologies LLC, Geode Capital Management LLC, California State Teachers Retirement System, Jane Street Group LLC, and New York State Common Retirement Fund.
View insider buying and selling activity for NewAge
or view top insider-selling stocks.

Which institutional investors are buying NewAge stock?

NBEV stock was purchased by a variety of institutional investors in the last quarter, including Trek Financial LLC, Marshall Wace LLP, Morgan Stanley, Vident Investment Advisory LLC, StoneX Group Inc., Perritt Capital Management Inc., SG Americas Securities LLC, and Symons Capital Management Inc.. Company insiders that have bought NewAge stock in the last two years include Ed Brennan, and Timothy J Haas.
View insider buying and selling activity for NewAge
or or view top insider-buying stocks.

How do I buy shares of NewAge?

Shares of NBEV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NewAge's stock price today?

One share of NBEV stock can currently be purchased for approximately $1.24.

How much money does NewAge make?

NewAge has a market capitalization of $169.62 million and generates $279.47 million in revenue each year. The company earns $-39.34 million in net income (profit) each year or ($0.32) on an earnings per share basis.

How many employees does NewAge have?

NewAge employs 1,127 workers across the globe.

What is NewAge's official website?

The official website for NewAge is newagebev.us.

Where are NewAge's headquarters?

NewAge is headquartered at 2420 17TH STREET SUITE 220, DENVER CO, 80202.

How can I contact NewAge?

NewAge's mailing address is 2420 17TH STREET SUITE 220, DENVER CO, 80202. The company can be reached via phone at (303) 566-3030 or via email at [email protected].

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.